You just read:

Ionis Pharmaceuticals Reports Positive Phase 2 Data for IONIS-FXI Rx in Patients with End-Stage Renal Disease on Hemodialysis

News provided by

Ionis Pharmaceuticals, Inc.

01 Nov, 2016, 07:00 ET